Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis C

  Free Subscription


Articles published in Transfusion

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    January 2021
  1. STEELE WR, Dodd RY, Notari EP, Haynes J, et al
    HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men.
    Transfusion. 2021 Jan 18. doi: 10.1111/trf.16250.
    PubMed     Abstract available


    October 2020
  2. COLEMAN C, Lelie N, Rademeyer R, van Drimmelen H, et al
    Comparison of two nucleic acid amplification technology systems for detection of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus.
    Transfusion. 2020 Oct 16. doi: 10.1111/trf.16137.
    PubMed     Abstract available


    September 2020
  3. AN T, Dean M, Flower R, Tatzenko T, et al
    Understanding occult hepatitis C infection.
    Transfusion. 2020;60:2144-2152.
    PubMed     Abstract available


    August 2020
  4. STEELE WR, Dodd RY, Notari EP, Xu M, et al
    Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS).
    Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005.
    PubMed     Abstract available


    June 2020
  5. BLOCH EM, Kipiani E, Shadaker S, Alkhazashvili M, et al
    Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.
    Transfusion. 2020;60:1243-1252.
    PubMed     Abstract available


    February 2020
  6. DENG X, Zang L, Wang X, Chen H, et al
    Follow-up program for blood donors with unconfirmed screening results reveals a high false-positive rate in Dalian, China.
    Transfusion. 2020;60:334-342.
    PubMed     Abstract available


  7. BLATYTA PF, Kelly S, Sabino E, Preiss L, et al
    Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.
    Transfusion. 2020;60:343-350.
    PubMed     Abstract available


    November 2019
  8. CANDOTTI D, Sauvage V, Cappy P, Boullahi MA, et al
    High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply.
    Transfusion. 2019 Nov 27. doi: 10.1111/trf.15593.
    PubMed     Abstract available


    July 2019
  9. FU P, Lv Y, Zhang H, Liu C, et al
    Hepatitis C virus prevalence and incidence estimates among Chinese blood donors.
    Transfusion. 2019 Jul 4. doi: 10.1111/trf.15432.
    PubMed     Abstract available


    October 2018
  10. UCHIDA S, Satake M, Kurisu A, Sugiyama A, et al
    Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study.
    Transfusion. 2018 Oct 30. doi: 10.1111/trf.14951.
    PubMed     Abstract available


    August 2018
  11. SEHEULT JN, Triulzi DJ, Kaplan A
    Targeted prospective hepatitis C virus "lookback" program: is it an efficient and effective use of resources?
    Transfusion. 2018;58:2084-2085.
    PubMed    


    April 2018
  12. BUTLER EK, McCullough J
    Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
    Transfusion. 2018;58:854-861.
    PubMed     Abstract available


    February 2018
  13. SHAN Z, Huang J, Liao Q, Huang K, et al
    Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14527.
    PubMed     Abstract available


  14. VAN REMOORTEL H, Borra V, De Buck E, Compernolle V, et al
    Is an endoscopic examination associated with transfusion-transmissible infections? A systematic review and meta-analysis.
    Transfusion. 2018;58:507-519.
    PubMed     Abstract available


    January 2018
  15. ROCHA D, Andrade E, Godoy DT, Fontana-Maurell M, et al
    The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
    Transfusion. 2018 Jan 30. doi: 10.1111/trf.14478.
    PubMed     Abstract available


    December 2017
  16. GALEL SA, Simon TL, Williamson PC, AuBuchon JP, et al
    Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14457.
    PubMed     Abstract available


    August 2017
  17. GAO Z, Zhang Y, Shan H, Shi L, et al
    A 30-year systematic review and meta-analysis of hepatitis B virus among blood donors in mainland China: revealing increase of new threats.
    Transfusion. 2017;57:1988-1997.
    PubMed     Abstract available


    July 2017
  18. TWAGIRUMUGABE T, Swaibu G, Bergstrom T, Walker TD, et al
    Low prevalence of hepatitis C virus RNA in blood donors with anti-hepatitis C virus reactivity in Rwanda.
    Transfusion. 2017 Jul 3. doi: 10.1111/trf.14204.
    PubMed     Abstract available


    June 2017
  19. VIEIRA PCM, Lamarao LM, Amaral CEM, Correa ASM, et al
    Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
    Transfusion. 2017 Jun 7. doi: 10.1111/trf.14146.
    PubMed     Abstract available


    May 2017
  20. CZERWINSKI M, Grabarczyk P, Stepien M, Kubicka-Russel D, et al
    What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.
    Transfusion. 2017 May 28. doi: 10.1111/trf.14163.
    PubMed     Abstract available


    April 2017
  21. BISWAS A, Firdaus R, Gupta D, Ghosh M, et al
    Interferon lambda3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Transfusion. 2017 Apr 16. doi: 10.1111/trf.14070.
    PubMed     Abstract available


    March 2017
  22. BLANCO S, Balangero MC, Valle MC, Montini OL, et al
    Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections.
    Transfusion. 2017;57.
    PubMed     Abstract available


    February 2017
  23. GUO Z, Fu P, Yin Y, Wang F, et al
    The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C
    Transfusion. 2017 Feb 5. doi: 10.1111/trf.14014.
    PubMed     Abstract available


    January 2017
  24. VENDRAMIN C, McGuckin S, Alwan F, Westwood JP, et al
    A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.
    Transfusion. 2017;57:131-136.
    PubMed     Abstract available


  25. GALLIAN P, Couchouron A, Dupont I, Fabra C, et al
    Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors.
    Transfusion. 2017;57:223-224.
    PubMed    


    October 2016
  26. MAFIRAKUREVA N, Mapako T, Khoza S, Emmanuel JC, et al
    Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Transfusion. 2016 Oct 2. doi: 10.1111/trf.13858.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: